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Introduction
The marijuana policy landscape is changing rapidly both in the United States and abroad. Despite a federal prohibition against marijuana in the United States, ten states have passed laws allowing commercial recreational marijuana markets to exist, and the nation's capital, Washington DC, has passed a law legalizing growing and possession for personal use. Several more states are considering similar legal changes either legislatively or through ballot initiatives. The relevance of these state laws is more than just symbolic, as they have encouraged other jurisdictions to do the same, with Uruguay (2013) , Jamaica (2015) , and most recently Canada (2017) all passing legislation enabling legal recreational marijuana markets (Kilmer and Pacula, 2017) .
While there is a clear expectation that legalization will reduce the criminal justice costs of prohibition and the racial disparities in enforcement and incarceration associated with it (Golub et al., 2007; Nguyen and Reuter, 2012; Nicosia et al., 2017) , there is considerable speculation about the impact of legal marijuana markets on recreational marijuana use and public health. As it is too early to evaluate the impact of these legal changes on recreational markets, many have tried to infer implications based on the state medical marijuana policy experiments. Substantial attention has been given to impacts of medical marijuana laws on static measures of recreational use, such as prevalence rates and frequency of use (Anderson et al., 2013 (Anderson et al., , 2015 Hasin et al., 2015; Pacula et al., 2015; Wen et al., 2015) . This body of work has shown that medical marijuana laws have spill-over effects on recreational markets, increasing adult recreational marijuana use. What remains unclear, however, is the extent to which the increase in marijuana use induced by medical marijuana laws is a result of decreased quitting among adult marijuana users, or an increase in uptake by this group.
Distinguishing between impacts on uptake and quitting is necessary for quantifying the full effect of legal marijuana markets. And given the evidence from the tobacco literature, it is unlikely that those making decisions about initiating and those who are deciding whether to quit respond to policies in the same way (DeCicca et al., 2008; Lillard et al., 2013) .
This study contributes to the literature in three key ways. First, our analyses extend beyond static measures of marijuana use by examining quitting behavior to demonstrate how the presence of legal markets for marijuana, whether legally protected are not, influences the duration of marijuana use. The duration of marijuana use is an outcome of considerable policy importance because it is long term use that is more strongly associated with adverse health and social impacts, including anxiety and depression, cardiovascular disease, respiratory problems, and reduced educational attainment (Anderson et al., 2013; Hall, 2015; Marie and Zölitz, 2017; McCaffrey et al., 2010; Moore et al., 2007; van Ours and Williams, 2009; Williams, 2011, 2012) . 1 Second, we describe how supply-side regulations of medical marijuana laws have evolved to create differential variation in on-the-ground access to retail markets for marijuana (de facto legalization of dispensaries) versus state legal protections for obtaining marijuana through retail channels (de jure legalization of dispensaries). Finally, we are the first to demonstrate the differential impact of de facto and de jure allowances for marijuana dispensaries across different racial/ethnic groups.
To estimate the impact of the medical marijuana retail environment on quitting, we link information on operating medical marijuana dispensaries and laws protecting them to self-reported longitudinal data on marijuana use from the 1997 National Longitudinal Survey of Youth. Geographic and temporal variation in the presence of operating dispensaries and laws protecting dispensaries serve to identify the impacts of these dimensions of the legal marijuana market on quitting behavior. Our results reveal no evidence that either the presence or legal protection of medical marijuana dispensaries impacts the decision to quit marijuana assuming homogeneous treatment effects.
However, a homogeneous treatment effect approach to studying the impact of legalized marijuana markets on quitting may mask important differences across race/ethnicity and gender, driven by differing costs under prohibition (MacCoun et al., 2009 ). For example, marijuana's criminal status is routinely used to justify searching individuals during a pretextual stop (Kreit, 2016) . 2 This practice is disproportionately applied to blacks and Hispanics, who are in turn disproportionately arrested and convicted for marijuana possession and sales offenses (Golub et al., 2007; Nguyen and Reuter, 2012; Ramchand et al., 2006) , with the most pronounced disparities for black males (Ramchand et al., 2006) . 3 The greater risk of arrest under criminalization for minority males suggests that their quitting behavior may be more responsive to legal protection of marijuana markets.
Allowing for heterogenous effects across race/ethnicity and gender reveals important differences in quitting responses to de facto and de jure legal markets for marijuana. Non-Hispanic white males delay quitting in response to the presence of operating retail dispensaries (de facto legalization), black males respond to the legal protection of retail dispensaries (de jure legalization), and Hispanic males delay quitting in response to both. We find little robust evidence that quitting by females responds to either the presence or protection of retail medical marijuana dispensaries. We conclude that the decision to quit using marijuana among men, and therefore the duration of use, is sensitive to whether de facto legal markets are operating. However, it is the legal protection of markets, and past the age when uptake generally occurs when the relevant marijuana policies are introduced. For example, the NLSY97 cohort are 20-24 when the first law protecting medical marijuana dispensaries came into effect on January 1, 2004.
2 Even if the motivation for police to stop and search an individual is not related to marijuana offenses, and the resulting arrest is not for a marijuana offense, appealing to suspicions about marijuana are sufficient to justify the stop and search.
3 Differential arrest risk by sex and race/ethnicity has also been documented in the longitudinal data used for the current study (NLSY97), with estimates showing significantly higher cumulative prevalence of arrest by age 18 and by age 23 among males relative to females, and among black males relative to whites males (Brame et al., 2014) . similar to the protection we are now observing for recreational markets, that will lead to further increases in duration of use for minorities, reflecting the higher costs they faced under prohibition.
The rest of the paper is organized as follows. Section 2 provides background information on the evolution of medical marijuana laws and medical marijuana dispensaries in the United States.
Section 3 describes the data used in the empirical analyses and Section 4 outlines the empirical framework for estimating the effects of medical marijuana laws on the marijuana cessation decision.
Our results are presented in Section 5, and Section 6 concludes.
Background on Medical Marijuana Laws and Dispensaries
State medical marijuana laws differ along a variety of dimensions, which have been discussed at length in several prior studies (Bradford and Bradford, 2018; Klieger et al., 2017; Pacula et al., 2015; Pacula and Smart, 2017; Sabia and Nguyen, 2018; Wen et al., 2015) . While little is known about the extent to which many of these dimensions are associated with access by recreational users Smart, 2016) , those related to dispensaries have received the greatest research attention given their demonstrated association with changes in prices, potency and market size (Anderson et al., 2013; Sevigny et al., 2014; Smart, 2016) . Given the clearer conceptual and empirical links between medical marijuana dispensary provisions and the supply of marijuana to both medical and recreational markets, we focus our discussion and empirical analyses on the presence and legal protections of this supply-side aspect of medical marijuana policy.
Evolution of Medical Marijuana Laws
Modern medical marijuana laws (MMLs), which provide explicit legal protections to patients and their caregivers for possession and use of marijuana for specific medical conditions, first emerged in 1996 with the passage of California's medical marijuana ballot initiative (Proposition 215). By 1999, four more states (Oregon, Washington, Alaska, and Maine) had followed suit, passing laws through similar ballot initiatives. These early MMLs provide patients and their caregivers legal protection from state prosecution for possessing and using marijuana for certain medical conditions as specified in the laws, and also protected doctors from legal state sanctions for discussing the medicinal use of marijuana with their patients. 4 Early state initiatives were purposefully vague regarding an explicit supply source for the marijuana, due to concerns about a response from the federal government which retained its prohibition (Pertwee, 2014) . To the extent that any source of supply was specified in these early laws, they typically allowed for home cultivation by patients and/or their caregivers, not dispensaries or group cultivation cooperatives . 5 The ambiguity of many of these early laws, combined with explicit federal opposition to state efforts toward liberalizing medical marijuana (Claiborne, 1997; Law, 2001; Newbern, 2000; Pertwee, 2014; Tiersky, 1998) , created an environment wherein actual legal protections afforded by MMLs may have been unclear to many of the potential actors involved, including physicians, patients, and suppliers. 6 While dispensaries and group cultivation cooperatives were not provided de jure legal protections under early state MMLs, the statutory language was ambiguous enough in California, Colorado and Montana to effectively permit the de facto operation of largely unregulated large-scale production, and medical marijuana dispensaries soon began to sprout up in these states.
The mid-2000s saw a shift toward MMLs with more precise regulatory language regarding supply sources, but continued threats of federal prosecution and federal raids of medical marijuana production sites remained an impediment to the development of regulated state systems (Mikos, 2009; Vickovic, 2011) . Conflict and lawsuits in California regarding the legitimacy of group cooperatives selling through retail outlets led to the passage of S.B. 420 in 2003, which amended California'a initial MML to explicitly allow for cooperative cultivation and sale to members. However, regulatory discretion of these newly protected legal entities was left to local governments, so as to keep the state out of the crosshairs of the Federal government. While New Mexico became the first state to enact a medical marijuana law that established legal provisions for state-licensed dispensaries in its July 2007 initial legislation (S.B. 523), threats of federal prosecution led to significant delays in licensing (Baker, 2007) . States that enabled home cultivation typically set a maximum allowable number of plants that could be cultivated (usually three mature plants), in order to reduce the potential risk patients might face if targeted by the federal government. Exceptions are Washington and California. Washington imposed a limit of a 60-day supply, without specifying a maximum number of plants. California was the only state that did not specify any limit . In 2000, Hawaii became the first state to enact a medical marijuana law through its state legislature, but it too specified home cultivation with strict limits on the number of plants as the only source of supply.
6 For instance, the month following California's passage of Proposition 215, then drug-czar Barry McCaffrey and Attorney General Janet Reno issued statements threatening to suspend the licenses of physicians who recommended marijuana to patients and to render their clinics ineligible for Medicare and Medicaid funding (Annas, 1997; Newbern, 2000) . While the enforceability of these federal threats was ruled against with the September 2000 decision in Conant v. McCaffrey, the appeals process continued until October 2003 (Kasprak, 2004) .
focus federal resources on individuals who are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana" (Ogden, 2009, p. 1-2) . State MMLs passed following this announcement have provided much more explicit and comprehensive state regulation and oversight of the supply chain, including oversight of cultivation, dispensaries and labeling of cannabis-derived products. 7 Some states that passed early laws subsequently modified their policies after the Ogden memo, providing more explicit protection and regulation of retail dispensaries for medical marijuana (e.g., Colorado in 2010).
Medical Marijuana Laws and Dispensaries Today
As of December 2018, thirty-three states and the District of Columbia had medical marijuana laws in effect, and the number continues to grow each year. All of these states, except Alaska, allow for legally protected dispensaries (see Table 1 for state laws in effect through 2017). distribution of medical marijuana has become more complex and burdensome. For example, the vast majority of states today regulate dispensary density, location and product source, while nearly half also regulate stocking levels (Klieger et al., 2017) . Structural requirements for dispensaries, cultivators, and processors are also imposed, with regulations related to safety and security, ventilation systems, hand washing stations, and even disposal. The development of these additional licensing requirements and regulations imposed on the cultivation, distribution and retail sale of medical marijuana have caused there to be significant lag times between the point at which a state adopts an MML allowing for dispensaries and the dispensaries actually opening, as indicated in Table 1 . This stands in stark contrast to states that adopted their initial medical marijuana law prior to 2010.
Today, legal protections provided to patients and suppliers through MMLs differ along a variety of other dimensions as well, including covered illnesses, registration requirements, cultivation allowances and rules, product safety and licensing (Klieger et al., 2017) . The specific privileges and requirements related to each of these dimensions have also varied widely across states and even within states over time. This substantial heterogeneity in approaches helps to explain why studies examining the impact of simple dichotomous measures of state medical marijuana laws on various outcomes at different points of time yield inconsistent and contradictory results (Anderson et al., 2013; Pacula et al., 2015; Pacula and Smart, 2017; Wen et al., 2015) .
Medical Marijuana Retail Markets and the Cost of Marijuana Use
Medical marijuana retail markets, and MMLs more generally, influence the cost of recreational marijuana use through two broad channels: 1) reducing its monetary price by lowering the legal risk faced by now legitimate medical suppliers bringing the drug to market, which reduces their production costs (Anderson et al., 2013; Hansen et al., 2017; Sevigny et al., 2014) , and 2) reducing the non-pecuniary costs associated with obtaining marijuana, including legal risks and search costs.
This second point warrants further explanation of how legal protections provided to medical users might be conferred on recreational users.
In principle, MMLs that provide legal protections from state criminal prosecution for the possession and use of specified quantities of marijuana should only benefit a limited set of individuals who qualify as medical marijuana patients. 9 However, these policies likely benefit recreational users as well. This is because early state laws tended to be broadly permissive in what constituted a qualifying condition, did not require a bona fide relationship between recommending physician and patient, and did not mandate that medical marijuana patients register with the state in order to receive legal protections (Mikos, 2009) . 10 The breadth of legal protections granted to MMLs patients without requirements for state registries make it difficult for law enforcement to differentiate medical users from recreational users. Further, the presence of medical dispensaries, whether legally protected or not, reduces the search costs associated with obtaining the product (Galenianos et al., 2012; Jacobi and Sovinsky, 2016; Pacula et al., 2010) . Recent work by Sabia and Nguyen (2018) supports the conclusion that at least some of the increase in use associated wtih medical marijuana laws on adult males comes from an increase in recreational use among males under the age of 30.
The reduction in the risk associated with purchasing and using marijuana when MMLs are in place, when dispensaries are legally protected, and when they operate but without protection, is likely to vary across groups depending on the expected risks they faced under a regime of marijuana prohibition (MacCoun et al., 2009 ). There is a well-established literature showing that blacks and Hispanics are disproportionately arrested and convicted, particularly in cases where there is 9 Individuals who use marijuana solely for medical purposes represent a tiny fraction of marijuana users. While 12.1% of the U.S. adult population report using marijuana for recreational purposes, only 0.8% report using marijuana for medicinal purposes only (Compton et al., 2017) .
10 The costs of becoming a legal medical marijuana patient include the monetary value of any patient registration fee in states that mandate registration, as well as the time costs of finding a doctor who will provide certification that the individual has a qualifying condition that could benefit from marijuana use. However, particularly when examining MMLs passed during this study's timeframe up to 2011, we anticipate these costs to be negligible.
greater discretion for police in choosing suspects or for courts in determining incarceration and sentencing (Geller and Fagan, 2010; Goel et al., 2016; Gross and Barnes, 2002; Mustard, 2001) . This has been shown specifically for marijuana possession and sales offenses (Golub et al., 2007; Nguyen and Reuter, 2012; Ramchand et al., 2006) , with the most pronounced disparities for black males (Ramchand et al., 2006) . 11 Similarly, the impact of MMLs, operating dispensaries, and laws protecting dispensaries may also differentially impact females compared to males given experimental evidence showing females exhibit greater risk aversion and greater sensitivity to social cues than their male counterparts (Croson and Gneezy, 2009; Eckel and Grossman, 2008) .
In light of these findings in the literature, we assume throughout the subsequent discussion that medical marijuana policies reduce legal risks and access costs to all potential marijuana users, both recreational and medical, allbeit to varying degrees for users from different race/ethnic groups and genders. It is this broader impact of medical marijuana policies, particularly those related to the operation and legal protection of dispensaries, on marijuana users that we seek to understand.
Data
Our analysis combines individual histories on marijuana use collected longitudinally in the National Longitudinal Survey of Youth 1997 (NLSY97) with state level information on the operating of medical marijuana dispensaries, general medical marijuana laws and laws providing legal protection to medical marijuana dispensaries.
NLSY97
The NLSY97 is a longitudinal survey representative of American youths who were 12-16 years old as of 31 December 1996. The first wave of the survey, fielded in 1997 and 1998, collected information on 8,984 individuals (4,599 males and 4,385 females). 12 Respondents were subsequently interviewed annually until wave 15, fielded in 2011. 13 We use data from the first 15 waves of the NLSY97, with each of these waves collecting detailed information on marijuana use, including retrospective information on age at first use, which is collected in wave 1. 14 Making use of both 11 Differential arrest risk by sex and race/ethnicity has also been documented in the longitudinal data used for the current study (NLSY97), with estimates showing significantly higher cumulative prevalence of arrest by age 18 and by age 23 among males relative to females, and among black males relative to whites males (Brame et al., 2014) .
12 Of the 8,984 originally surveyed, 6,748 composed a representative cross-sectional sample and 2,236 compose a supplement that over-sampled Hispanics and blacks who were born in the same time period as the representative sample. We use both in our analysis.
13 The retention rate for wave 15 is 85.6%. The NLSY97 data has continued beyond 2011. However, the next wave of the survey is 2013 -two years later -and does not include questions on marijuana or illicit drug use. We therefore stop our analysis in 2011.
14 The information used in this paper was reported by the youth. The only exception is parental characteristics which were reported by the youths' parents in 1997.
the retrospective and annually collected data allows us to construct marijuana use histories for this large, representative sample covering the period 1990-2011. 15 
Marijuana Use Histories and the Duration of Use
Of the 8,984 interviewed in wave 1, we observe information on whether or not marijuana is used in at least one round of the survey for 8,922 individuals (4,558 males and 4,364 females). The duration of each person's marijuana use is calculated from the age of first use and the age of last use. The age at first use is self-reported for those who report having ever used marijuana in wave 1. For individuals who do not report using in wave 1, the age at first use is based on information provided in subsequent waves on whether the respondent had used marijuana since the date of the last interview (SDLI). The age of last use is defined as the age at the survey in which the respondent last reported using marijuana. Duration of use is calculated using information on the age at which the respondent last reported marijuana use combined with the age at first use. For those individuals who are not observed to quit use, their duration of marijuana use is censored at the age at which they were last surveyed (and reported marijuana use).
The Medical Marijuana Retail Environment
As our interest in this paper is on the decision to quit use and previous research in the alcohol and tobacco literature demonstrate the importance of retail outlets on uptake and quitting (Chen et al., 2010; Halonen et al., 2013; Reitzel et al., 2011) , we focus here on two specific aspects of state medical marijuana policy environments: operating dispensaries, measured by an indicator equal to one for states in months and years in which a dispensary system is known to operate even if it is not legally protected, and legal protection for medical marijuana dispensaries, measured by an indicator equal to one for states that legally protects dispensaries to sell marijuana to patients within the state (based on month and year of the law's effective date). In some states (CA, CO, MT and WA) dispensary systems operated in specific locations prior to any legal authorization -these are our examples of de facto markets. In other states (NM, NY, MA) these dispensary systems took years to put in place and open even after the laws providing legal protections were passed. Those states with laws explicitly allowing retail dispensaries to operate are considered de jure markets. In addition, we account for whether states have passed any medical marijuana law using a dichotomous indicator which is set equal to one in month-years when a given state has an effective policy providing legal protection to patients who use marijuana for medicinal purposes.
Information on state medical marijuana laws, including legal protections of dispensaries, were collected through original legal research of state statutes and regulations conducted under a series of projects funded by the National Institute on Drug Abuse and the Robert Wood Johnston Foundation Pacula et al., 2002 Pacula et al., , 2015 . The dates at which states provided these legal protections to patients and their caregivers, as well the dates when legal protections were provided to dispensaries, are shown in Table 1 . Detailed information on the process for identifying whether a state legally provides a patient access to marijuana for medicinal purposes or protects retail medical marijuana dispensaries is discussed in Powell et al. (2018) . As several state policies presented in Table 1 were adopted outside of the NLSY sample period we are evaluating (1997-2011), we indicate those state policies which provide variation for identification using an asterisk.
As mentioned in Section 2, several states that adopted early medical marijuana laws did not provide explicit legal protection to dispensaries, yet dispensaries were known to operate. We identified dates for dispensaries operating in these states through an extensive web search. 16 Active dates were determined as the earliest month and year in which an open dispensary was either discussed or advertised in a mainstream news outlet (e.g., local TV news agency, website or newspaper).
These are reported in Table 1 .
The marijuana policy variables are merged onto individual's marijuana use histories on the basis of the state in which they live. Critical to our approach is measuring the policy environment in place during the recall period over which survey respondents are deciding whether to quit marijuana use. Noting that at each survey wave, individuals report on their use of marijuana "since the last interview" as well as their current residential location, the relevant policy regime will be the regime in place just prior at the start of the survey wave's reporting period, which is the day of the "last interview."
Measurement Issues
A potential threat to the reliable estimation of the causal effects of operating dispensaries and laws protecting them is that of measurement error in the reporting of marijuana use. Since our analysis is based on longitudinal data which records annual information on respondents use of marijuana, the possibility that errors are made in accurately remembering this information is minimized. Similarly, the regular questioning of NLSY97 respondents regarding marijuana use from relatively early ages 16 The web search targeted two primary sources: (1) webpages produced by marijuana advocacy groups either informing patients of where to get marijuana or linking to dispensary webpages, such as Weedmaps, the National Organization for the Reform of Marijuana Laws (www.norml.org), Marijuana Policy Project (www.mpp.org); and (2) key word searches of old local newspapers and weekly circulars, using terms such as "medical marijuana" and "dispensary" or "cooperative." Three separate policy analysts independently conducted these searches and then convened to discuss consistency in their findings. also insures against a failure to report experimental use. 17
A second potential source of measurement error arises in matching state level information on the medical marijuana retail environment to the respondent's state of residence at each age that the respondent is at risk of quitting marijuana use. However, as we observe respondents' state of residence at each interview, we are able to capture movements across state borders, mitigating the risk of measurement error with respect to the medical marijuana retail regime faced when making decisions regarding quitting. Of course, this raises the question of whether individuals move across state borders in order to access retail marijuana markets. We examine this issue in a sensitivity analysis. Table 2 provides information on marijuana use by gender and race/ethnicity. In terms of gender, 60% of males and 53% of females report using marijuana and amongst those who have ever used, males and females report a similar age at first use; 16.6 years for males and 16.8 for females. In addition to being more likely to report using marijuana, males are also less likely to be observed to quit use, with 65% of males quitting compared to 72% of females. Conditional on quitting, males and females quit at similar ages having used for similar durations; on average males are 20.8 years old when they quit, having used for 5.1 years and females are on average 20.9 when they quit, having used for 4.9 years.
Descriptive Statistics
In terms of race and ethnicity, Table 2 shows that amongst females, non-Hispanic white females are more likely to report ever using marijuana than black or Hispanic females (60% of non-Hispanic white females compared to 44% of black and 48% of Hispanic females). Non-Hispanic white and black females are less likely to quit than Hispanic females, with 71% of non-Hispanic white and black females quitting compared to 75% of Hispanic females. Amongst those who use, black females tend to start later than non-Hispanic white and Hispanic females, and amongst those who quit Hispanic females tend to quit at younger ages. As a result, non-Hispanic white females have the longest average duration of use at 5.3 years, and black females have the shortest, at 4.3 years.
Amongst males, non-Hispanic white males and black males have similar rates of marijuana use (61 and 62% respectively), while Hispanic males are less likely to report use (57%). Black and Hispanic males are more likely than non-Hispanic white males to quit marijuana use, with quit 17 Harrison et al. (2007) investigate the validity of self-reported drug use information in a general population survey in the US by comparing the self-reports of respondents with the results of drug tests of urine specimens. For marijuana, 93% of individuals self-reported use in the past 3 days agreed with their urine sample, 5.2% of those who reported no use tested positive and 1.8% reported using and tested negative. The authors also investigates whether there were differences in truthfulness of self-reports by age, comparing 12-17 year olds with those aged 18-25. Overall, both age-groups reported their drug use accurately, with 3% under-reporting 3 day use amongst 12-17 year olds compared to 8% under-reporting 3 day use 18-25 year olds.
rates for black and Hispanic males of 67 and 68% respectively, compared to 62% for non-Hispanic white males. Among those who ever use, Non-Hispanic white males are slightly younger than their minority peers when they start marijuana use and, among those who quit, they are slightly older when they quit. As a consequence, non-Hispanic white males tend to use for longer than minority males, with white males using for 5.3 years on average compared to 4.8 and 4.5 for black and Hispanic males, respectively.
In addition to very detailed information on marijuana use, the NLSY97 provides rich information on the respondents and the households in which they grow up that we control for in our analysis.
Sample averages for the control variables for the full sample and for the sub-sample of marijuana users is shown in Appendix There are three main points to take from Figure 1 . First, the hazard of quitting has a common pattern across gender and race/ethnicity; it spikes after the first year of use, and is subsequently relatively constant. 19 Second, within gender, the spike in quitting after the first year of use is greater for minorities than for non-Hispanic whites, and across gender the spike in quitting after the first year of use is greater for females than males. The final point to take from Figure 1 is that, for both females and males, the cumulative quit rate (which shows the proportion who have quit) is higher at each duration of use for minorities than for non-Hispanic whites, although the difference is greater amongst males. Table 3 shows the average rate of quitting marijuana use by whether individuals live in a state that has MMLs, operating dispensaries, or legal protection for dispensaries. This information is provided for the full sample and by gender. For the full sample, and for each gender, the average quit rate is also provided by race/ethnicity (non-Hispanic white versus minorities, defined as black or Hispanic).
Medical Marijuana Dispensaries and Quitting Marijuana Use
From Table 3 it is evident that the quit rate is generally lower in states in which the MM environment is more liberal. For example, non-Hispanic white males living in a state with operating medical marijuana dispensaries are, on average, 1.60 percentage points less likely to quit compared to non-Hispanic white males living in a state without operating dispensaries (7.92% compared to 9.52%), and minority males are 1.57 percentage points less likely to quit if they live in a state that provides legal protection for dispensaries compared to minority males living in a state where dispensaries are not legally protected (10.29% compared to 11.86%). Minority females are an exception; the quit rate of minority females is in fact higher in states with more liberal MM environments. For example, minority females living in a state with operating dispensaries are 1.95 percentage points more likely to quit, on average, compared to minority females living in a state without operating dispensaries (14.94% compared to 12.99%).
Empirical Framework
We consider a framework in which marijuana users decide whether or not to quit at each duration of use by comparing the costs and benefits of doing so. As discussed above, medical marijuana retail markets, and related laws, impact this decision by reducing the monetary and non-pecuniary costs associated with search time and legal risk of marijuana possession and use, which together we will refer to as the total cost.
The extent to which the medical marijuana environment impacts the total cost of marijuana use may differ by gender, race or ethnicity. Minorities in general, and blacks in particular, may be more sensitive to legal protections being extended to medical marijuana dispensaries given their greater risk of arrest (Geller and Fagan, 2010; Nguyen and Reuter, 2012; Ramchand et al., 2006) .
Similarly, sex differences in risk aversion and sensitivity to social cues (Croson and Gneezy, 2009; Flynn et al., 1994) may also result in differential effects of the legal protection of medical marijuana dispensaries on marijuana use across gender. We investigate these potential sources of heterogeneity in our empirical analysis.
Hazard Model for Quitting Marijuana Use
Our baseline empirical strategy uses a difference-in-differences (DID) setup, exploiting state and time variation in the operating of retail medical marijuana dispensaries and legal protections provided to them to estimate their impact on the decision to quit use. The usual framework for doing 13 so is based on an empirical model of the form
where y it is an indicator equal to one if individual i living in state s quits marijuana use in period t, δ s is a vector of state fixed effects, γ t is a vector of year fixed effects, and M M st is the vector of policy variables (M 1st , M 2st , M 3st ) where M 1st is an indicator for general medical marijuana law in place, (M 2st ) is an indicator for operating dispensaries, and (M 3st ) is an indicator for laws explicitly protecting medical marijuana dispensaries. The vector of parameters of interest, (β), identify the causal effect of retail medical marijuana markets under the parallel trends assumption.
As commonly done in the literature, the validity of the parallel trends assumption can be examined using leads and lags of policy indicators. Doing so, the event study can be expressed as:
Because the outcome that we are studying is the decision to quit marijuana use, and as shown in Figure 1 , a feature of quitting behaviour is that it exhibits duration dependence (and duration of use may be censored), we adapt the standard DID framework to a duration setting (Bartik and Nelson, 2017; Williams and Bretteville-Jensen, 2014) . To do so, we embed the DID setup of equation 1 into a proportional hazard model. However, as our analysis is based on a discrete time measure of marijuana use (measured at each survey wave), we follow (Bartik and Nelson, 2017; Bretteville-Jensen, 2014) who adopt the discrete time analogue of the proportional hazard model,
given by the complementary log-log hazard (clog-log), which has the following form: 20
where the hazard h it (j) characterizes the probability that person i at time t quits marijuana use at duration of use j given that they have not quit use at duration j − 1, and α j represents duration dependence, which is modelled non-parametrically. 21
The interpretation of the (exponentiated) coefficients is in terms of hazard ratios and the analog to the linear model's difference-in-difference is the ratio of (hazard) ratios. For example, the coefficient on the indicator for state s having a law protecting dispensaries in year t is interpreted as the percentage change in the hazard of quitting marijuana use associated with a state adopting legal protections for medical marijuana dispensaries between period t−1 and time period t, relative to the change that occurs over the same period of time in a state which remains dispensary free. This is measured by (exp(β 3 ) − 1) * 100, where β 3 is the coefficient on the indicator for the state having a law protecting medical marijuana dispensaries.
In order for the vector of parameters, β is be interpreted as the causal impact of the medical marijuana retail environment on the hazard of quitting, the equivalent of the parallel trends assumption from equation 1 must hold. The analogous assumption for our setting is that log continuous-time quitting hazards evolved along parallel trends in states that did and did not have operating or protected dispensaries (see Bartik and Nelson (2017) 
The interpretation of the event-time coefficient β k 3 , for example, is the ratio of the change in the hazard of quitting in states with legal protection for dispensaries in the kth period after (or before for k < 0) their law came into effect relative to states that do not provide legal protection for medical marijuana dispensaries.
The empirical setup presented above assumes that the effect of the medical marijuana retail variables on the decision to quit marijuana use do not vary by individual characteristics. We relax this assumption to allow for differences across gender by estimating the hazard model for quitting separately over subsamples of females and males. We also wish to allow for differences within gender across race/ethnicity. In order to maintain reasonable sample sizes for estimation, we allow for differences for non-Hispanic whites and minorities (for both males and females) by interacting the vector of state policy variables, M M st , the state and year indicators, and all controls in X ist with separate indicators for race/ethnicity is non-Hispanic white and race/ethnicity is minority (black or Hispanic). We extend this approach to allow for differences for blacks and Hispanics separately in our extended robustness analysis. All models are estimated using maximum likelihood, and we report standard errors that are clustered at the state level. Table 4 reports maximum likelihood coefficient estimates from the baseline DID model for quitting marijuana use. We report specifications estimated over the full sample in column 1, and over the female and male subsamples in columns 2 and 3, respectively. Panel A reports estimates for specifications that assume homogeneous treatment effects with respect to race/ethnicity. In panel B, we relax this assumption, allowing for the treatment effect for non-Hispanic whites to differ from the treatment effect for minorities (defined as Hispanics and blacks). 22
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Results
Baseline Results
As can be seen from Panel A of Table 4 , the DID estimates based on the pooled sample of females and males and assuming homogenous policy effects across non-Hispanic whites and minorities provides no evidence that MMLs, operating dispensaries or laws protecting them impact on the decision to quit marijuana use. However, the results from estimating this specification for females and males separately suggest that there are differences across gender in the impact of the policy environment on quitting marijuana use. While we are unable to detect any statistically significant impact on females' decision to quit use in response to any of the medical marijuana policy variables, including the presence or legal protection of medical marijuana dispensaries, the same is not true of males. We find that living in a state with operating retail medical marijuana dispensaries reduces the hazard of quitting marijuana use amongst males by 20% (exp(-0.22)-1).
And while not reaching statistical significance at conventional levels, the presence of laws protecting medical marijuana dispensaries is estimated to reduce the hazard of quitting marijuana use of males by 10% (p-value=0.16). We find that living in a state in which dispensaries are both active and protected reduces the likelihood of males quitting marijuana use by 28% at each duration of use, and this effect is statistically significant (p-value = 0.003). The different findings for males and females are not surprising in light of previous studies that find gender differences in the responsiveness of substance use to changes in the policy environment (Nelson, 2014; Wen et al., 2015) . Table 4 demonstrates that imposing a homogeneous response across race/ethnicity to the medical marijuana policy environment can also mask important differences between nonHispanic whites and minorities. Specifically we find that living is a state with operating dispensaries reduces the hazard of quitting marijuana of non-Hispanic white males by around 28% (= exp(−0.33 − 1)). While we we find no evidence that non-Hispanic white males' decision to quit marijuana use is impacted by living in a state that provides legal protection to medical marijuana dispensaries, living in a state with a general MML increases their quit rate. Noting that states with operating dispensaries also have general MMLs, we find no net effect of living in a state with both an MML and operating dispensaries for non-Hispanic white males (p-value=0.90) . This is because the decrease in quitting in response to operating dispensaries is offset by an increase in quitting in response to general MMLs by non-Hispanic white males.
Panel B of
In contrast to their non-Hispanic white peers, living in a state that provides legal protection to medical marijuana dispensaries reduces the quit rate of minority men. The point estimate implies a 21% reduction in quitting following legal protection for dispensaries coming into effect relative to living is a state where they remain unprotected. 23 We also find that both living in a state with a general MML and living in a state with operating dispensaries reduces the quit rate of minority men (by 14 and 16%, respectively), although each of these effects is imprecisely estimated. In the case of operating dispensaries, the impact for minority men is not statistically different from the impact on non-Hispanic white men (p-value=0.63), which is estimated to reduce quitting by 28%.
Overall, we conclude that while we find no robust evidence that the medical marijuana policy environment impacts on quitting behavior of females, there is evidence of significant effects for males and these effects differ across racial/ethnic groups. While we find no evidence that legal protection of medical marijuana dispensaries impacts on the quit rate of non-Hispanic white males, general MMLs and operating dispensaries having offsetting effects for this group of males. In contrast, we find that minority men are less likely to quit marijuana use when they live is a state with laws that legally protect dispensaries, and weaker evidence suggests that this group may also reduce quitting in response to operating dispensaries.
Robustness
The interpretation of the DID estimator as providing causal estimates of the impact of the policy variables on the decision to quit marijuana use relies on the parallel trends assumption. In order to investigate this assumption, we conduct an event study analysis which involves including leads and lags of the policy variables in the hazard model, as described in section 4.1. Evidence of an impact of the policy variables in years preceding their introduction suggests differing trends in treatment and controls states in the pre-treatment period, which is inconsistent with the parallel trends assumption.
We present the results from the event study analysis in graphical form for males in Figure 2 Looking down the first column of graphs reveals no evidence of a significant pre-trend in the coefficients on general medical marijuana laws for non-Hispanic white males. For minority males, there is some evidence that quit rate is lower in the year before medical marijuana laws are introduced than in the first year they are in effect. Looking down the second column of graphs, we find no evidence of pre-trends in the coefficients on operating dispensaries for either non-Hispanic white males or minority males. Finally, the third column graphs leads and lags for laws providing protection for dispensaries. While it provides no evidence of pre-trends for non-Hispanic white males, there is some evidence that the quit rate was lower among minority males in states that introduced laws protecting dispensaries at t=-2, corresponding to 2 or more full years before the law became effective. However, there is no difference in the quit rates between minority men living in states that do not introduce laws to protect medical marijuana dispensaries and states that do at t=-1, corresponding to the year before the policy is introduced.
To further probe the issue of identification in our DID model, we include state and race/ethnicity specific linear trends in our baseline specification. The results from estimating this model over the subsample of males are reported in column 2 of Table 5 . Column 1 repeats the baseline results from Table 4 column 3 for ease of reference. As can be seen from Table 5 , including state and race specific time trends has little impact on the estimated impact of the medical marijuana policy variables for white males, and strengthens the estimated impact for minorities. This provides some reassurance that the baseline estimates can be interpreted as causal.
The third column of Table 5 investigates the extent to which our findings reflect endogenous sorting by marijuana users into states that have operating medical marijuana dispensaries, or laws to protect them. We examine this issue by removing from our sample individuals from the time they move to a state with a operating dispensaries, or laws in effect that protect them. 25 As can be seen from Table 5 , column 3, removing observations on individuals who are potentially sorting into states with retail markets for medical marijuana reduces the magnitude of the point estimates on operating dispensaries for non-Hispanic whites and protected dispensaries for minorities, with the former loosing statistical significance at conventional levels (p-value of 0.11). Nonetheless our findings are not qualitatively changed, leading us to conclude that our results are not entirely explained by endogenous sorting.
The final column of Table 5 attempts to tease out the separate impacts of the medical marijuana measures on Hispanic and black men. To do this, we replace the non-white interaction terms with separate interaction terms with an indicator for race is black, and interaction terms with ethnicity is Hispanic. This is quite taxing for the data given the relatively limited information on minorities in the NLSY97. Nonetheless, the results reveal a significant difference in the behavioural response of Hispanic and black men to the medical marijuana environment. Specifically, the estimates indicate that Hispanic men, but not black men, respond to operating dispensaries in their state of residence by reducing their quit rate, as do non-Hispanic white men. We note that although the impact of legal protection for dispensaries for Hispanic men is imprecisely estimated, it is not significantly different from the statistically significant impact for black males, as shown in the bottom panel of Table 5 .
Discussion
The significant differences across gender and race/ethnicity on quitting marijuana arising from these policies raises the question, "By how much is the duration of marijuana use extended by the presence and legal protection of dispensaries?" We now turn to answering this question.
In order to quantify the impact of operating medical marijuana dispensaries and their legal protection on quitting, we conduct simulations using the parameter estimates from Table 5 , in which the policy variables are permitted to have differing effects for blacks, Hispanics, and nonHispanic whites. Because we find robust evidence that quitting behavior of males, but not females, is impacted by the presence and protection of medical marijuana dispensaries, we conduct simulations for males only. The simulations show the cumulative probability of quitting marijuana after each year of use for non-Hispanic white males in the first panel, for black males in the second panel, and for Hispanic males in the third panel. In each panel, the solid line depicts the evolution of the cumulative probability of quitting in the absence of MMLs, operating dispensaries and laws protecting them, and the dashed line shows the evolution on the cumulative probability of quitting when MMLs, operating dispensaries and laws protecting them are all in place.
As is clear from Figure 3 , the proportion of non-Hispanic white male marijuana users who have quit is the same at all durations of use under either policy scenario. This is because the reduction in quitting that occurs in response to operating dispensaries is offset by an increase in quitting in response to generic MMLS, and because this group does not change their quitting behaviour in response to laws protecting medical marijuana dispensaries (and the coefficient on this variable for non-Hispanic white males is small, in addition to being statistically insignificant). The implications of these longer use durations is uncertain, although the literature suggests larger downstream health and social impacts (Marie and Zölitz, 2017; van Ours and Williams, 2009; Williams, 2011, 2012) . Extending marijuana use careers through encouraging longer durations of sporadic, casual use will have meaningfully different impacts than through increased durations of chronic, heavy use; and the actual effects will most certainly depend on the potency of the products consumed, method of ingestion, and frequency of use. Researchers are just beginning to pay attention to the relevance of these aspects of use, and thus it seems too early to know the health implications of these increases in durations of use for minority males.
Conclusion
Previous work has shown that medical marijuana laws have spill-over effects on recreational markets, increasing adult recreational marijuana use, particularly among males (Sabia and Nguyen, 2018) .
It is unclear, however, the extent to which this increase in use is a result of decreased quitting among adult marijuana users, or an increase in uptake among this group. To shed light on this issue, we study the decision to quit, focusing on how retail medical marijuana dispensaries and laws protecting them impact quitting behavior. The presence of an operating dispensary, regardless of its legal status, may delay quitting by reducing the search time associated with finding marijuana.
Legally protected dispensaries lower not just search costs, but also the monetary cost (because suppliers face lower production costs due to their own reduction in legal risk) and legal risk faced by the user. To investigate their effects on quitting, we link information on dispensaries operating marijuana use for non-Hispanic white males is 6 years. and legal protections of them to self-reported longitudinal data on marijuana use from the 1997 National Longitudinal Survey of Youth. Geographic and temporal variation in the presence of operating dispensaries and their legal protection serve to identify the impact of these dimensions of the legal marijuana market on quitting behavior.
Our results highlight the importance of allowing for heterogeneous effects of legal marijuana markets on measures of marijuana use by race and ethnicity. When we impose homogeneity on the impacts of the presence of retail dispensaries and of laws protecting them across gender and race/ethnicity we find no evidence that either the presence or protection of medical marijuana dispensaries impact on the decision to quit marijuana use. Allowing for heterogeneous effects reveal important differences across gender and race/ethnicity; non-Hispanic white males delay quitting in response to the presence of operating retail dispensaries suggesting they are more sensitive to the time and monetary factors. Black males respond to the legal protection of retail dispensaries but not operating dispensaries, suggesting they are more sensitive to the legal risk. Hispanic males delay quitting in response to both the legal protection and presence of operating retail medical marijuana dispensaries, suggesting they are responsive to reductions in all components of cost. We find little robust evidence that quitting by females responds to either the presence or protection of retail medical marijuana dispensaries. We conclude that the decision to quit using marijuana among men, and therefore the duration of use, is sensitive to both de facto retail markets and de jure retail markets, although racial and ethnic differences in responsiveness to each of these types of markets can mask their effects. The sensitivity by minorities to legal risks imposed by different policies is not surprising in light of their increased risk of arrest for simple marijuana offenses, particularly for black males.
Because earlier incantations of medical marijuana dispensary laws were subject to less stringent state oversight, our findings may better reflect the potential effects of recent recreational marijuana policies than the more"medicalized" MMLs passed since 2010. The relevance of these findings in light of recent state laws to legalize recreational marijuana is that they suggest such liberalization policies may help reduce the racial and ethnic disparities associated with prohibition in the United States, particularly among blacks. This could represent an important benefit of these policies that is not fully reflected in criminal justice savings. However, the results also suggest that it is important to understand quickly whether there are differential impacts of legalized markets on patterns of use by various ethnic groups. We find that de jure legalization reduces quitting and increases the duration of use amongst minority men. In the absence of further information on the frequency and intensity of use, as well as the the strength of marijuana product used, is unclear whether and to what extent this behavior will translate into differential health impacts, further exasperating health disparities amongst minority men. Note: Standard errors clustered at the state level in parentheses; *** p<0.01, ** p<0.05, * p<0.1. Controls include: ability (standardized CAT-ASVAB score corrected for years of schooling at the test date), indicators for year of birth, mother a teen at the respondents birth, responding parent is very religious, parents' education (of the mother and father separately), mother's parenting style is authoritarian parenting style,(log of) household income and (log of) household size, living in urban location, indicators for state of residence, indicators for calendar year. Duration dependence is modelled flexibly using a set of indicators for duration of use. Column 3 drops individuals from the time they move to a state that has operating retail dispensaries or effective laws protecting them. The figure shows the results of an event-time analysis of the difference on the complementary log-log of the marijuana quitting rate (ie ln(-ln(1-quitting rate))) between states that have a MML, operating dispensaries, and laws protecting dispensaries and those that do not before and after the change came into effect. The reported coefficients are from estimating a version of the baseline model ( Table 4) that includes interactions between indicators for living in a state with the policy and indicators for event time. Event time is defined as the calendar year of survey minus the year that the policy came into effect. Error bars show 95% confidence intervals generated from standard errors clustered at the state level. The figures show the predicted evolution of the cumulative quitting rate for a male with the average standardized level of ability, born in 1981 living with both parents who each have more than a high school education, with a mother was not a teen at the time of the respondent's birth and has an authoritarian parenting style, whose (log) household income and (log) family size in the first wave is equal to the sample average. Solid lines represent the cumulative quitting rates with no MML, no dispensaries and no laws protecting dispensaries. Dashed lines assumes a general MML, operating dispensaries and laws protecting them are in place. 
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